EUVIMEDEUVIMED entdecken
Crossref

Development of a biotechnology process for the production of a novel hyperglycosylated long‐acting recombinant bovine follicle‐stimulating hormone

Javier Villarraza iD, Sebastián Antuña iD, María Belén Tardivo iD, María Celeste Rodríguez iD, Pablo Uriel Díaz iD, Ulises Sebastián Notaro iD, Hugo Héctor Ortega iD, Claudio Prieto iD, Natalia Ceaglio iD

Biotechnology Journal · 2024-06 · 19 (6)

DOI: 10.1002/biot.202400260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 20.06.2024. Verfasst von Javier Villarraza und 8 weiteren Autor:innen. Beteiligte Einrichtung: UNL (Universidad Nacional del Litoral), CBL (Centro Biotecnológico del Litoral), LDB (Laboratorio de Desarrollo Biotecnológico), Ciudad Universitaria…. Hauptthemen laut MEDLINE: Follicle Stimulating Hormone, Cricetulus, Recombinant Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ministerio de Desarrollo Productivo, Universidad Nacional del Litoral (UNL).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicle‐stimulating hormone (FSH) is an important protein used for bovine ovarian hyperstimulation in multiple ovulation and embryo transfer technology (MOET). Several attempts to produce bovine FSH (bFSH) in recombinant systems have been reported, nonetheless, up to date, the most commonly used products are partially purified preparations derived from porcine or ovine (pFSH or oFSH) pituitaries. Here we describe the development of a biotechnology process to produce a novel, hyperglycosylated, long‐acting recombinant bFSH (LA‐rbFSH) by fusing copies of a highly O‐glycosylated peptide. LA‐rbFSH and a nonmodified version (rbFSH) were produced in suspension CHO cell cultures and purified by IMAC with high purity levels (>99%). LA‐rbFSH presented a higher glycosylation degree and sialic acid content than rbFSH. It also demonstrated a notable improvement in pharmacokinetic properties after administration to rats, including a higher concentration in plasma and a significant (seven‐fold) reduction in apparent clearance ( CL app ). In addition, the in vivo specific bioactivity of LA‐rbFSH in rats was 2.4‐fold higher compared to rbFSH. These results postulate this new molecule as an attractive substitute for commercially available porcine pituitary‐derived products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Follicle Stimulating HormoneCricetulusRecombinant ProteinsAnimalsCHO CellsGlycosylationCattleRatsFemaleBiotechnology

Stichwörter der Autor:innen

O‐glycosylationbioprocessglycoengineeringglycoprotein hormonepharmacokinetics

Substanzen

Follicle Stimulating HormoneRecombinant Proteins

Autor:innen und Institutionen

  • UNL (Universidad Nacional del Litoral), CBL (Centro Biotecnológico del Litoral), LDB (Laboratorio de Desarrollo Biotecnológico), Ciudad Universitaria, Santa Fe, Argentina.
  • CONICET (Consejo Nacional de Investigaciones Científicas y Técnicas), Santa Fe, Argentina.
  • Biotecnofe S.A. Parque Tecnológico Litoral Centro (PTLC), Santa Fe, Argentina.
  • UNL (Universidad Nacional del Litoral), FBCB (Facultad de Bioquímica y Ciencias Biológicas), Cátedra de Química Analítica II, Ciudad Universitaria, Santa Fe, Argentina.
  • Centro de Medicina Comparada, Instituto de Ciencias Veterinarias del Litoral (ICiVet-Litoral), Universidad Nacional del Litoral (UNL)/Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Esperanza, Sant…
  • UNL (Universidad Nacional del Litoral), FBCB (Facultad de Bioquímica y Ciencias Biológicas), CBL (Centro Biotecnológico del Litoral), LCC (Laboratorio de Cultivos Celulares), Ciudad Universitaria, Santa Fe, Argentina.

ORCID-Profile: Javier Villarraza, Sebastián Antuña, María Belén Tardivo, María Celeste Rodríguez, Pablo Uriel Díaz, Ulises Sebastián Notaro, Hugo Héctor Ortega, Claudio Prieto, Natalia Ceaglio

Förderung

  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)
  • Ministerio de Desarrollo Productivo
  • Universidad Nacional del Litoral (UNL)

Zitieren

APA

Villarraza, J., Antuña, S., Tardivo, M. B., Rodríguez, M. C., Díaz, P. U., Notaro, U. S., Ortega, H. H., Prieto, C., & Ceaglio, N. (2024). Development of a biotechnology process for the production of a novel hyperglycosylated long‐acting recombinant bovine follicle‐stimulating hormone. Biotechnology Journal, 19(6). https://doi.org/10.1002/biot.202400260

Vancouver

Villarraza J, Antuña S, Tardivo MB, Rodríguez MC, Díaz PU, Notaro US, et al. Development of a biotechnology process for the production of a novel hyperglycosylated long‐acting recombinant bovine follicle‐stimulating hormone. Biotechnology Journal. 2024;19(6). doi:10.1002/biot.202400260

BibTeX
@article{Villarraza2024,
  author = {Villarraza, Javier and Antuña, Sebastián and Tardivo, María Belén and Rodríguez, María Celeste and Díaz, Pablo Uriel and Notaro, Ulises Sebastián and Ortega, Hugo Héctor and Prieto, Claudio and Ceaglio, Natalia},
  title = {Development of a biotechnology process for the production of a novel hyperglycosylated long‐acting recombinant bovine follicle‐stimulating hormone},
  journal = {Biotechnology Journal},
  year = {2024},
  volume = {19},
  number = {6},
  doi = {10.1002/biot.202400260}
}
Kostenlos starten →